Home Categories Send inquiry

News

Bioendo’s Arrangement on International Workers’ Day

Bioendo, the expert of bacterial endotoxin and beta-glucan detection, will have 4 days off for May Day, which will last from May 1st to May 4th. Reply during the holiday may be slow, but we will come back to you ASAP once the holiday finishes. If you need something urgent, please contact us now.... Read More

COVID-19 vaccine developed by China’s Sinopharm for emergency use, validated by WHO.

COVID-19 vaccine developed by China’s Sinopharm for emergency use,validatedby WHO. The World Health Organization (WHO) validated on May seventh the BBIBP-CorV COVID-19 vaccine developed by China’s Sinopharm for emergency use. This afternoon, WHO gave emergency use listing to Sinophar... Read More

Chinese New Year Holiday

Bioendo will close the office from January 19th to February 1st , 2020 to celebrate Chinese New Year. Our support team will still answer emails through the holiday. However, please be patient as our response time may be a little slower than usual. The Chinese New Year, a.k.a. Spring Festival, is... Read More

Application of Chromogenic Technique to Bacterial Endotoxins Test

Chromogenic technique is among the three techniques which also contain gel-clot technique and turbidimetric technique to detect or quantify endotoxins from Gram-negative bacteria by using amoebocyte lysate extracted from the blue blood of horseshoe crab (Limulus polyphemus or Tachypleus tridenta... Read More

Chromogenic TAL Assay EC64405

TAL reagent, i.e. the lyophilized amebocyte lysate extracted from the blue blood of horseshore crab (Limulus polyphemus or Tachypleus tridentatus), is always employed to do bacterial endotoxins test. At Xieman Bioendo Technology Co., Ltd., we manufacturer kits to perform the end-point chromogeni... Read More

Bioendo, Invited to the China Marine Economy Expo.

The 2019 China Marine Economy Expo., co-hosted by Ministry of Natural Resources of the P.R. China and and People’s Government of Guangdong Province and undertaken by Shenzhen Municipal Government, is held in Shenzhen during Oct. 14th to Oct. 17th with the topic of “Blue Opportunities; Create the... Read More

Bioendo TAL Reagent Was Used In Professional Field

Bioendo TAL Reagent Was Used In Etanercept Inhibits Pro-Inflammatory Cytokines Expression In Titanium Particle-Stimulated Peritoneal Macrophages Failure The publification “Etanercept Inhibits Pro-inflammatory Cytokines Expression in Titanium Particle-Stimulated Peritoneal Macrophages Failure” us... Read More

Chromogenic TAL Assay (Chromogenic endotoxin test assay)

Chromogenic TAL Assay (Chromogenic endotoxin test assay) TAL reagent is the lyophilized amebocyte lysate which is extracted from the blue blood of Limulus polyphemus or Tachypleus tridentatus. Endotoxins are amphiphilic lipopolysaccharides (LPS) located in the outer cell membrane of gram-negativ... Read More

Bioendo in Analitica Latin America with Booth No. CP06-1

Analitica Latin America will be held at Transamerica Exhibition Center in Sao Paulo during Sep. 24th and Sep. 26th, 2019. Bioendo will attend the Analitica Latin America. Our Booth No. is CP06-1. Your visit is welcome. Xiamen Bioendo Technology Co., Ltd., founded in 1978, is the expert in the fi... Read More

Bioendo Will Attend India Lab Expo

The ILE, i.e. India Lab Expo which concentrates on medical industry, analysis, environment, food and biotechnology field, will be held during September 19th – 21st, 2019. Xiamen Bioendo Technology Co., Ltd., founded in 1978 and the expert in the field of endotoxins and Fungi (1,3)-β-D-glu... Read More

Kits for TAL Test by Using Kinetic Chromogenic Method

TAL test, i.e. bacterial endotoxin test as defined on USP, is a test to detect or quantify endotoxins from Gram-negative bacteria using ameobocyte lysate extracted from the horseshoe crab (Limulus polyphemus or Tachypleus tridentatus). The kinetic-chromogenic assay is a method to measure either ... Read More

With Bioendo assistance, the China’s first GMP certified vaccine product approved use by the EU and launched in the EU market

At the end of 2019, the new crown epidemic was fierce. In December 2020, the inactivated new crown virus vaccine developed and produced by a well-known biopharmaceutical company was 86% effective against virus infection, and the neutralizing antibody conversion rate was 99%, which can be 100% pre... Read More
<< < Previous 12345 Next > >> Page 3 / 5